articleProceedings of the National Academy of SciencesOct 29, 2013BRONZE OA

Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration

University of California San Diego · Ludwig Cancer Research · +3 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Expanded hexanucleotide repeats in the chromosome 9 open reading frame 72 (C9orf72) gene are the most common genetic cause of ALS and frontotemporal degeneration (FTD). Here, we identify nuclear RNA foci containing the hexanucleotide expansion (GGGGCC) in patient cells, including white blood cells, fibroblasts, glia, and multiple neuronal cell types (spinal motor, cortical, hippocampal, and cerebellar neurons). RNA foci are not present in sporadic ALS, familial ALS/FTD caused by other mutations (SOD1, TDP-43, or tau), Parkinson disease, or nonneurological controls. Antisense oligonucleotides (ASOs) are identified that reduce GGGGCC-containing nuclear foci without altering overall C9orf72 RNA levels. By…

Citation impact

556
total citations
FWCI
37.18
Percentile
100%
References
60
Citations per year

Authors

30

Topics & keywords

Keywords
  • C9orf72
  • Frontotemporal lobar degeneration
  • Sense (electronics)
  • Degeneration (medical)
  • Frontotemporal dementia
  • RNA
  • Biology
  • Chemistry
No related works found for this paper.